AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation (Q39568204)

13 September 2017

title

AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation (English)

1 reference

13 September 2017

0 references

0 references

Xiao-Hong Li

1

1 reference

13 September 2017

Bing-Ling Lv

2

1 reference

13 September 2017

Jia-Zhao Xie

3

1 reference

13 September 2017

Jing Liu

4

1 reference

13 September 2017

Xin-Wen Zhou

5

1 reference

13 September 2017

Jian-Zhi Wang

6

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21450369

28 November 2024

publication date

29 March 2011

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0197458011000169?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

https://api.elsevier.com/content/article/PII:S0197458011000169?httpAccept=text/plain

28 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

28 November 2024

published in

Neurobiology of Aging

1 reference

13 September 2017

volume

33

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

1400-1410

1 reference

Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice

28 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations

28 November 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia

28 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

The use of the Morris Water Maze in the study of memory and learning

28 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2.

28 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.

28 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.

28 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

28 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

28 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.

28 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells

28 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Linking type 2 diabetes and Alzheimer's disease

28 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Tau pathology in Alzheimer disease and other tauopathies

28 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Mechanisms of tau-induced neurodegeneration

28 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons

28 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

An immunochemical study on tau glycation in paired helical filaments

28 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products

28 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms

28 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.

28 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide

28 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Metabolic links between diabetes and Alzheimer's disease.

28 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

28 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease

28 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.

28 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction

28 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

28 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

28 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B.

28 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Microtubule-associated protein tau in development, degeneration and protection of neurons

28 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

28 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

28 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

28 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Hepatocyte growth factor prevents advanced glycation end products-induced injury and oxidative stress through a PI3K/Akt-dependent pathway in human endothelial cells

28 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments

28 November 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine

28 November 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.02.003

28 November 2024

Identifiers

1 reference

13 September 2017

1 reference